News - 2020
November 18, 2020 News
Oblique Therapeutics AB raises 98 MSEK
in a private placement investment round.
October 19, 2020 News
This is our first Abiprot patent.
We hope that many more will follow.
October 8, 2020 News
Oblique Therapeutics AB together with collaborators
at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK.
September 21, 2020 Event
24th Sept 2020 – Oblique Therapeutics
is delighted to be invited to speak at “Biopharma Conclave 2020”.
September 14, 2020 Event
Oblique Therapeutics is honored to participate
as speaker to the 2nd Edition RAS-Targeted Drug Development Congress 15th September 2020.
June 29, 2020 News
Oblique Therapeutics and Targovax enter collaboration
to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms.
June 11, 2020 News
Oblique Therapeutics AB has identified
a potentially important epitope for generation of SARS-CoV-2 antibodies.
June 4, 2020 News
General Meeting 2020
Oblique Therapeutics AB – Notice to the annual general meeting 2020.